Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL9655363 | 0.96 | TSHR (0.46) | ALDH1A1TSHR | |
| Ethylene Glycol SCHEMBL7195215 | 0.86 | TSHR (0.36) | ALDH1A1TSHR | |
| Ethylene Glycol SCHEMBL231666 | 0.81 | TSHR (0.39) | ALDH1A1TSHR | |
| Propane SCHEMBL1683354 | 0.81 | TSHR (0.36) | ALDH1A1TSHR | |
| Methyl Alcohol SCHEMBL1172804 | 0.81 | ALDH1A1 (0.43) | ALDH1A1TSHR | |
| Methane SCHEMBL30637 | 0.80 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| Ethylene Glycol SCHEMBL17199782 | 0.79 | TSHR (0.36) | ALDH1A1TSHR | |
| Butane SCHEMBL3799640 | 0.77 | TSHR (0.33) | ALDH1A1TSHR | |
| Methane SCHEMBL759221 | 0.76 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| Hydrogen Peroxide SCHEMBL20917732 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009053697-A1 | POLYMORPHIC FORMS OF ( S ) -ROTIGOTINE HYDROCHLORIDE | PLIVA HRVATSKA D.O.O. (HR) | 2009-04-30 | — | — | WO | claimed |
| US-20210363300-A1 | STARTING MATERIAL FOR BULK DRUG OR ADDITIVES FOR DRUG, AND BULK DRUG OR DRUG USING SAME | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2021-11-25 | — | — | US | disclosed |
| EP-3733208-A1 | STARTING MATERIAL FOR BULK DRUG OR ADDITIVES FOR DRUG, AND BULK DRUG OR DRUG USING SAME | Sanyo Chemical Industries, Ltd. (JP) | 2020-11-04 | — | — | EP | disclosed |
| EP-3250291-B1 | CRYSTALLINE C21H22C12N4O2 MALONATE | BIOMED VALLEY DISCOVERIES INC (US) | 2020-08-26 | — | — | EP | disclosed |
| US-9951041-B2 | Crystalline C21H22Cl2N4O2 malonate | BIOMED VALLEY DISCOVERIES, INC. (US) | 2018-04-24 | — | — | US | disclosed |
| EP-3250291-A1 | CRYSTALLINE C21H22C12N4O2 MALONATE | Biomed Valley Discoveries, Inc. (US) | 2017-12-06 | — | — | EP | disclosed |
| US-20170320850-A1 | CRYSTALLINE C21H22Cl2N4O2 MALONATE | ALBANY MOLECULAR RESEARCH, INC. | 2017-11-09 | — | — | US | disclosed |
| EP-2975035-B1 | SALT OF PYRROLIDIN-3-YL ACETIC ACID DERIVATIVE AND CRYSTALS THEREOF | EISAI R&D MAN CO LTD (JP) | 2017-08-02 | — | — | EP | disclosed |
| US-9670177-B2 | Crystalline C21H22Cl2N4O2 malonate | BIOMED VALLEY DISCOVERIES, INC. (US) | 2017-06-06 | — | — | US | disclosed |
| US-9550732-B2 | Salt of pyrrolidin-3-yl acetic acid derivative and crystals thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2017-01-24 | — | — | US | disclosed |
| US-20160221988-A1 | CRYSTALLINE C21H22Cl2N4O2 MALONATE | BIOMED VALLEY DISCOVERIES, INC. | 2016-08-04 | — | — | US | disclosed |
| WO-2016123581-A1 | CRYSTALLINE C21H22C12N4O2 MALONATE | BIOMED VALLEY DISCOVERIES, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| EP-2975035-A1 | SALT OF PYRROLIDIN-3-YL ACETIC ACID DERIVATIVE AND CRYSTALS THEREOF | Eisai R&D Management Co., Ltd. (JP) | 2016-01-20 | — | — | EP | disclosed |
| US-20160002165-A1 | SALT OF PYRROLIDIN-3-YL ACETIC ACID DERIVATIVE AND CRYSTALS THEREOF | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
| WO-2009053697-A1 | POLYMORPHIC FORMS OF ( S ) -ROTIGOTINE HYDROCHLORIDE | PLIVA HRVATSKA D.O.O. (HR) | 2009-04-30 | — | — | WO | disclosed |
| US-5434159-A | Neurodegenerative disorders | STERLING WINTHROP INC. (US) | 1995-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160221988-A1 | CRYSTALLINE C21H22Cl2N4O2 MALONATE | MAL2, ME1, SLC22A11 | ALDH1A1 881/4885TSHR 4528/4885 |
| US-20160002165-A1 | SALT OF PYRROLIDIN-3-YL ACETIC ACID DERIVATIVE AND CRYSTALS THEREOF | ACP3, PKD1, ACMSD | ALDH1A1 167/4885TSHR 3670/4885 |
| US-20170320850-A1 | CRYSTALLINE C21H22Cl2N4O2 MALONATE | MAL2, ME1, SLC22A11 | ALDH1A1 881/4885TSHR 4528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.